Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
November 2026 94
2026-11
2026-11
2026-11
2026-11
Primary completion The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02973529
2026-11
Study completion Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04760717
2026-11
Primary completion Zenith® Fenestrated+ Clinical Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04875429
2026-11
Primary completion Harmony TPV Post-Approval Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05077774
2026-11
2026-11
2026-11
Study completion Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05371470
2026-11
Primary completion Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05371470
2026-11
Study completion Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05836831
2026-11
Primary completion Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05836831
2026-11
2026-11
Study completion The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06321575
2026-11
Primary completion The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06321575
2026-11
Study completion Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06449833
2026-11
Primary completion Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06449833
2026-11
2026-11
Study completion Avalus Ultra Post-Approval Study (PAS) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06506903
2026-11
Primary completion Avalus Ultra Post-Approval Study (PAS) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06506903
2026-11
2026-11
Primary completion Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy(RECAST-MT) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06559241
2026-11
Primary completion Study EHR Risk Stratification Tools Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06995378
2026-11
Study completion A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07021976
2026-11
2026-11
Study start CGM Use in Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07045298
2026-11
2026-11
Study completion Preeclampsia and Fetal Heart Malformations: Looking to Maternal Heart Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07092644
2026-11
Primary completion Preeclampsia and Fetal Heart Malformations: Looking to Maternal Heart Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07092644
2026-11
Study start Boston Medical Center Ultrasound Decongestion Study in Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07096726
2026-11
2026-11
Primary completion A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07215312
2026-11
Primary completion Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07241338
2026-11
Study start Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07376447
2026-11
2026-11
Study start Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07779746
2026-11
Study start Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07795593
2026-11
2026-11
2026-11
2026-11
2026-11
Study start MSC Secretome and rTMS for Motor Recovery After Subacute Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07874269
2026-11
2026-11
Study start A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07904507
2026-11
2026-11
Study start Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07911124
2026-11
Study start ADVA ACE Coronary Stent System in Coronary Artery Disease Patients (ADVANCE) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07912541
2026-11
2026-11
Study start A Study of Bimagrumab in Participants With HFpEF Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07920887
2026-11
2026-11
Study start Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07925502
2026-11
2026-11
Study start Very-Low-Field MRI for the Diagnosis of Acute Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07930013
2026-11
2026-11-19
Study completion Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06615726
2026-11-19
Primary completion Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06615726
2026-11-20
Study start A Study to Evaluate Cenvacibart (REGN7508) for Secondary Stroke Prevention in Adult Participants Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07876492
2026-11-20
Study start Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07914660
2026-11-20
2026-11-20
2026-11-20
2026-11-23
2026-11-24
2026-11-24
2026-11-26
Study completion Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07122401
2026-11-26
Primary completion Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07122401
2026-11-26
2026-11-27
Primary completion LATAM LOWERS LDL-C Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06501443
2026-11-28
2026-11-28
2026-11-28
Study completion Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07033585
2026-11-29
Study completion LATAM LOWERS LDL-C Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06501443
2026-11-30
Primary completion Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05020535
2026-11-30
Study completion Empagliflozin in Hypertrophic Cardiomyopathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05182658
2026-11-30
Primary completion Evaluation and Prediction of the Effect of EECP on HR-NICE Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05718622
2026-11-30
Primary completion NAD Augmentation in Diabetes Kidney Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05759468
2026-11-30
Primary completion The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1 Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06030843
2026-11-30
Primary completion Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06170944
2026-11-30
Study completion Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06250257
2026-11-30
2026-11-30
2026-11-30
Primary completion Point-of-Care Troponin Testing in the Emergency Department Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06845826
2026-11-30
2026-11-30
2026-11-30
Primary completion Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06979726
2026-11-30
2026-11-30
Primary completion Connected Care for Type 2 Diabetes Self-Management Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07149610
2026-11-30
2026-11-30
2026-11-30
2026-11-30
2026-11-30
2026-11-30
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2010-10
Primary completion Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients Registry record
Expected 2010-10; that period ended on 2010-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01061320
2010-10
Primary completion Body Composition Monitor in Hemodialysis Patients Registry record
Expected 2010-10; that period ended on 2010-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01103167
2010-12
Study completion Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients Registry record
Expected 2010-12; that period ended on 2010-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01061320
2010-12
Study completion Body Composition Monitor in Hemodialysis Patients Registry record
Expected 2010-12; that period ended on 2010-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01103167
2010-12
Study completion Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery Registry record
Expected 2010-12; that period ended on 2010-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01171911
2010-12
Primary completion Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery Registry record
Expected 2010-12; that period ended on 2010-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01171911
2011-02
Study completion Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus Registry record
Expected 2011-02; that period ended on 2011-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01206647
2011-02
Primary completion Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus Registry record
Expected 2011-02; that period ended on 2011-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01206647
2011-03
Primary completion The Effects of Preoperative Aspirin on Graft Patency and Cardiac Events in Off-pump Coronary Artery Bypass Registry record
Expected 2011-03; that period ended on 2011-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01268917
2011-03
Primary completion The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris Registry record
Expected 2011-03; that period ended on 2011-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01325818
2011-04
Primary completion Far Infrared Therapy on Peripheral Artery Disease in Hemodialysis Patients Registry record
Expected 2011-04; that period ended on 2011-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01095549
2011-04
Primary completion Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS Registry record
Expected 2011-04; that period ended on 2011-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01245803
2011-05
Study completion Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS Registry record
Expected 2011-05; that period ended on 2011-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01245803
2011-06
Study completion Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI Registry record
Expected 2011-06; that period ended on 2011-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01158846
2011-06
Primary completion Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI Registry record
Expected 2011-06; that period ended on 2011-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01158846
2011-06
Primary completion Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria Registry record
Expected 2011-06; that period ended on 2011-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01230034
2011-07
Study completion Antiproteinuric Effect of Imidapril Versus Ramipril in Type 2 Diabetic and Hypertensive Patients With Microalbuminuria Registry record
Expected 2011-07; that period ended on 2011-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01230034
2011-09
2011-09
Study completion Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement Registry record
Expected 2011-09; that period ended on 2011-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01331902
2011-09
Primary completion Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement Registry record
Expected 2011-09; that period ended on 2011-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01331902
2011-10
Primary completion Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients Registry record
Expected 2011-10; that period ended on 2011-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01040936
2011-10
Primary completion Phase 2 Study of Oral K201 for Prevention of AF Recurrence Registry record
Expected 2011-10; that period ended on 2011-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01067833
2011-10
Study completion Telmisartan, Amlodipine and Flow Mediated Dilation Registry record
Expected 2011-10; that period ended on 2011-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01180205
2011-10
Primary completion Telmisartan, Amlodipine and Flow Mediated Dilation Registry record
Expected 2011-10; that period ended on 2011-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01180205
2011-10
Primary completion Safety and Efficacy Registry of Yinyi Stent (SERY-II) Registry record
Expected 2011-10; that period ended on 2011-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01373658
2011-11
Study completion Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients Registry record
Expected 2011-11; that period ended on 2011-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01040936
2011-11
Primary completion Efficacy and Safety of the YUKON Drug Eluting Stent in Diffuse Coronary Artery Disease Registry record
Expected 2011-11; that period ended on 2011-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01418794
2011-12
Study completion Phase 2 Study of Oral K201 for Prevention of AF Recurrence Registry record
Expected 2011-12; that period ended on 2011-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01067833
2011-12
Primary completion Atorvastatin Plus Ezetimibe on Coronary Plaque Progression Registry record
Expected 2011-12; that period ended on 2011-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01086020
2011-12
2011-12
Study completion Safety and Efficacy Registry of Yinyi Stent (SERY-II) Registry record
Expected 2011-12; that period ended on 2011-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01373658
2012-01
2012-02
2012-02
Primary completion Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes Registry record
Expected 2012-02; that period ended on 2012-02-29.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01528059
2012-03
Primary completion A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization Registry record
Expected 2012-03; that period ended on 2012-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01157455
2012-03
Primary completion Organization Program of DiabEtes INsulIN ManaGement Registry record
Expected 2012-03; that period ended on 2012-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01338376
2012-03
Primary completion Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients Registry record
Expected 2012-03; that period ended on 2012-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01386853
2012-03
Primary completion Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension Registry record
Expected 2012-03; that period ended on 2012-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01413048
2012-03
Study completion Managing Diabetes During Pregnancy in the Wireless Age Registry record
Expected 2012-03; that period ended on 2012-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01474525
2012-03
Primary completion Managing Diabetes During Pregnancy in the Wireless Age Registry record
Expected 2012-03; that period ended on 2012-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01474525
2012-04
Primary completion Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes Registry record
Expected 2012-04; that period ended on 2012-04-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01220622
2012-05
Study completion Organization Program of DiabEtes INsulIN ManaGement Registry record
Expected 2012-05; that period ended on 2012-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01338376
2012-05
Primary completion Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape) Registry record
Expected 2012-05; that period ended on 2012-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01361425
2012-05
Study completion Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia Registry record
Expected 2012-05; that period ended on 2012-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01564875
2012-05
Primary completion Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia Registry record
Expected 2012-05; that period ended on 2012-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01564875
2012-05
Primary completion Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel Therapy Registry record
Expected 2012-05; that period ended on 2012-05-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01572129
2012-06
Primary completion Lycopene Following Aneurysmal Subarachnoid Haemorrhage Registry record
Expected 2012-06; that period ended on 2012-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT00905931
2012-06
Primary completion Comparison of Stent and Prothesis Bypass in Superficial Femoral Artery Registry record
Expected 2012-06; that period ended on 2012-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01147419
2012-06
Primary completion Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease Registry record
Expected 2012-06; that period ended on 2012-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01373632
2012-06
Primary completion Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study Registry record
Expected 2012-06; that period ended on 2012-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01378715
2012-06
Study completion Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol Registry record
Expected 2012-06; that period ended on 2012-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT01425164
2012-06
Primary completion Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol Registry record
Expected 2012-06; that period ended on 2012-06-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT01425164
2012-07
2012-07
Study completion Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes Registry record
Expected 2012-07; that period ended on 2012-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01220622
2012-07
Study completion Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia Registry record
Expected 2012-07; that period ended on 2012-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01229566
2012-07
Primary completion Efficacy Study to Treat Subjects With Severe Hypertriglyceridemia Registry record
Expected 2012-07; that period ended on 2012-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01229566
2012-07
2012-07
Primary completion Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations Registry record
Expected 2012-07; that period ended on 2012-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01320397
2012-07
Primary completion Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome Registry record
Expected 2012-07; that period ended on 2012-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01372839
2012-07
Study completion Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients Registry record
Expected 2012-07; that period ended on 2012-07-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01386853
2012-08
Study completion Rosuvastatin Pre-Treatment Influences the Risk of Coronary Intervention Study Registry record
Expected 2012-08; that period ended on 2012-08-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01378715
2012-09
Study completion Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease Registry record
Expected 2012-09; that period ended on 2012-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT00930436
2012-09
Study completion Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension Registry record
Expected 2012-09; that period ended on 2012-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01413048
2012-09
Primary completion Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial Registry record
Expected 2012-09; that period ended on 2012-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01555658
2012-09
Study completion Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting Registry record
Expected 2012-09; that period ended on 2012-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01572623
2012-09
Primary completion Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting Registry record
Expected 2012-09; that period ended on 2012-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT01572623
2012-09
Study completion RAAS Inhibitor Drugs in Dialysis Patients Registry record
Expected 2012-09; that period ended on 2012-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01635387
2012-09
Primary completion RAAS Inhibitor Drugs in Dialysis Patients Registry record
Expected 2012-09; that period ended on 2012-09-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01635387
2012-10
Study completion Lycopene Following Aneurysmal Subarachnoid Haemorrhage Registry record
Expected 2012-10; that period ended on 2012-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT00905931
2012-10
Study completion Efficacy Trial of Intracranial Aneurysm Treatment Using Two Different Endovascular Techniques Registry record
Expected 2012-10; that period ended on 2012-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT01084681
2012-10
Primary completion Efficacy Trial of Intracranial Aneurysm Treatment Using Two Different Endovascular Techniques Registry record
Expected 2012-10; that period ended on 2012-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT01084681
2012-10
Primary completion Value Antiproteinuric Effects From Vitamin D Derivatives in Patient With Chronic Kidney Illness and the Lack of Vitamin D Registry record
Expected 2012-10; that period ended on 2012-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01442272
2012-10
Primary completion Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study Registry record
Expected 2012-10; that period ended on 2012-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01462188
2012-10
Study completion Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial Registry record
Expected 2012-10; that period ended on 2012-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01555658
2012-10
Primary completion Renal Effects of an Angiotensin Converting Enzyme Inhibitor in Adults With Chronic Kidney Disease of Uncertain Aetiology Registry record
Expected 2012-10; that period ended on 2012-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01624064
2012-11
Primary completion Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease Registry record
Expected 2012-11; that period ended on 2012-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01155128
2012-12
Study completion Atorvastatin Plus Ezetimibe on Coronary Plaque Progression Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01086020
2012-12
Study completion Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01155128
2012-12
Primary completion Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01175486
2012-12
Primary completion Comparison of Effect of cARvedilol Compared To bISoprolol on cenTral Pulse Pressure in Hypertension (ARTIST) Study Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01243827
2012-12
Primary completion Optimizing Diagnostics Of Syncope Events Using Intelligent Telemetric Solutions. Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01265290
2012-12
Primary completion Optimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01265771
2012-12
Primary completion Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01278186
2012-12
Study completion Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01320397
2012-12
Primary completion The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01334671
2012-12
2012-12
Primary completion Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01499407
2012-12
Primary completion The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01633359
2012-12
Study completion DEDICA (Dose of HEparin During Coronary Angioplasty) Trial Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01694459
2012-12
Primary completion DEDICA (Dose of HEparin During Coronary Angioplasty) Trial Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01694459
2012-12
Primary completion Very Early Rehabilitation in Acute Ischemic Stroke Registry record
Expected 2012-12; that period ended on 2012-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01694992
2013-01
Study completion Optimizing Diagnostics Of Syncope Events Using Intelligent Telemetric Solutions. Registry record
Expected 2013-01; that period ended on 2013-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01265290
2013-01
Study completion Optimizing Diagnostics Of Arrhythmia Events In Children Using Intelligent Telemetric Solutions Registry record
Expected 2013-01; that period ended on 2013-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01265771
2013-01
Primary completion Safety and Effectiveness of the Coronary Momo Stent Registry record
Expected 2013-01; that period ended on 2013-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01535625
2013-01
Primary completion Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 Registry record
Expected 2013-01; that period ended on 2013-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01664637
2013-02
Study completion Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape) Registry record
Expected 2013-02; that period ended on 2013-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01361425
2013-02
2013-02
Study completion Diabetic Gastroparesis Efficacy/Safety Study of TZP-102 Registry record
Expected 2013-02; that period ended on 2013-02-28.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01664637
2013-03
Study completion The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI Registry record
Expected 2013-03; that period ended on 2013-03-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT01334671
2013-03